Cite
MLA Citation
Michael Weinblatt et al.. “Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population.” Arthritis research & therapy, vol. 17, no. 1, 2015, pp. 1–13. http://access.bl.uk/ark:/81055/vdc_100080340533.0x00018f